Citation 12360

LIN,CN: CHUNG,MI: LIOU,SJ: LEE,TH: WANG,JP:. (1996). SYNTHESIS AND ANTI-INFLAMMATORY EFFECTS OF XANTHONE DERIVATIVES.. 48(5)

Citation Details

Title	SYNTHESIS AND ANTI-INFLAMMATORY EFFECTS OF XANTHONE DERIVATIVES.
Authors	LIN,CN: CHUNG,MI: LIOU,SJ: LEE,TH: WANG,JP:
Year	1996
Volume	48
Issue	5

Summary

Year: 1996

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	COMPLETE SYNTHESIS REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FOR	XANTHONE,2-HYDROXY:	None
2	BETA-GLUCURONIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,2-HYDROXY:	INACTIVE
3	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,2-HYDROXY:	INACTIVE
4	SUPEROXIDE PRODUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,2-HYDROXY:	WEAK ACTIVITY
5	BETA-GLUCURONIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,2-HYDROXY:	WEAK ACTIVITY
6	LYSOZYME RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,2-HYDROXY:	WEAK ACTIVITY
7	Not specified	COMPLETE SYNTHESIS REPORTED	XANTHONE,3-HYDROXY:	None
8	BETA-GLUCURONIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,3-HYDROXY:	ACTIVE
9	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,3-HYDROXY:	WEAK ACTIVITY
10	SUPEROXIDE PRODUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,3-HYDROXY:	INACTIVE
11	BETA-GLUCURONIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,3-HYDROXY:	INACTIVE
12	LYSOZYME RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,3-HYDROXY:	INACTIVE
13	Not specified	COMPLETE SYNTHESIS REPORTED	XANTHONE,2-3-DIHYDROXY:	None
14	BETA-GLUCURONIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,2-3-DIHYDROXY:	INACTIVE
15	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,2-3-DIHYDROXY:	INACTIVE
16	SUPEROXIDE PRODUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,2-3-DIHYDROXY:	ACTIVE
17	BETA-GLUCURONIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,2-3-DIHYDROXY:	ACTIVE
18	LYSOZYME RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,2-3-DIHYDROXY:	ACTIVE
19	Not specified	COMPLETE SYNTHESIS REPORTED	XANTHONE,3-4-DIHYDROXY:	None
20	BETA-GLUCURONIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,3-4-DIHYDROXY:	INACTIVE
21	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,3-4-DIHYDROXY:	INACTIVE
22	SUPEROXIDE PRODUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,3-4-DIHYDROXY:	WEAK ACTIVITY
23	BETA-GLUCURONIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,3-4-DIHYDROXY:	WEAK ACTIVITY
24	LYSOZYME RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,3-4-DIHYDROXY:	INACTIVE
25	Not specified	COMPLETE SYNTHESIS REPORTED	XANTHONE,1-3-DIHYDROXY:	None
26	BETA-GLUCURONIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,1-3-DIHYDROXY:	ACTIVE
27	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,1-3-DIHYDROXY:	ACTIVE
28	SUPEROXIDE PRODUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,1-3-DIHYDROXY:	WEAK ACTIVITY
29	BETA-GLUCURONIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,1-3-DIHYDROXY:	ACTIVE
30	LYSOZYME RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,1-3-DIHYDROXY:	INACTIVE
31	Not specified	COMPLETE SYNTHESIS REPORTED	ATHYRIOL,NOR:	None
32	BETA-GLUCURONIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ATHYRIOL,NOR:	WEAK ACTIVITY
33	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ATHYRIOL,NOR:	WEAK ACTIVITY
34	COMPLEMENT-CLASSICAL PATHWAY STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	ATHYRIOL,NOR:	WEAK ACTIVITY
35	BETA-GLUCURONIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ATHYRIOL,NOR:	ACTIVE
36	LYSOZYME RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ATHYRIOL,NOR:	WEAK ACTIVITY
37	ANTIINFLAMMATORY ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	ATHYRIOL,NOR:	ACTIVE
38	Not specified	COMPLETE SYNTHESIS REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FOR	EUXANTHONE	None
39	BETA-GLUCURONIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EUXANTHONE	INACTIVE
40	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EUXANTHONE	INACTIVE
41	SUPEROXIDE PRODUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EUXANTHONE	WEAK ACTIVITY
42	LYSOZYME RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EUXANTHONE	WEAK ACTIVITY
43	Not specified	COMPLETE SYNTHESIS REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FOR	XANTHONE,2-5-DIHYDROXY:	None
44	BETA-GLUCURONIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,2-5-DIHYDROXY:	INACTIVE
45	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,2-5-DIHYDROXY:	INACTIVE
46	SUPEROXIDE PRODUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,2-5-DIHYDROXY:	WEAK ACTIVITY
47	BETA-GLUCURONIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,2-5-DIHYDROXY:	ACTIVE
48	LYSOZYME RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,2-5-DIHYDROXY:	WEAK ACTIVITY
49	Not specified	COMPLETE SYNTHESIS REPORTED	XANTHONE,2-6-DIHYDROXY:	None
50	BETA-GLUCURONIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,2-6-DIHYDROXY:	INACTIVE
51	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,2-6-DIHYDROXY:	INACTIVE
52	SUPEROXIDE PRODUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,2-6-DIHYDROXY:	INACTIVE
53	BETA-GLUCURONIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,2-6-DIHYDROXY:	WEAK ACTIVITY
54	LYSOZYME RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,2-6-DIHYDROXY:	INACTIVE
55	Not specified	COMPLETE SYNTHESIS REPORTED	XANTHONE,3-6-DIHYDROXY:	None
56	BETA-GLUCURONIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,3-6-DIHYDROXY:	INACTIVE
57	SUPEROXIDE PRODUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,3-6-DIHYDROXY:	WEAK ACTIVITY
58	BETA-GLUCURONIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,3-6-DIHYDROXY:	INACTIVE
59	LYSOZYME RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,3-6-DIHYDROXY:	INACTIVE
60	Not specified	COMPLETE SYNTHESIS REPORTED	XANTHONE,3-5-DIHYDROXY:	None
61	BETA-GLUCURONIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,3-5-DIHYDROXY:	ACTIVE
62	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,3-5-DIHYDROXY:	ACTIVE
63	SUPEROXIDE PRODUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,3-5-DIHYDROXY:	INACTIVE
64	BETA-GLUCURONIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,3-5-DIHYDROXY:	INACTIVE
65	LYSOZYME RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,3-5-DIHYDROXY:	INACTIVE
66	ANTIINFLAMMATORY ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	XANTHONE,3-5-DIHYDROXY:	ACTIVE
67	Not specified	COMPLETE SYNTHESIS REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FOR	XANTHONE,1-3-6-TRIHYDROXY:	None
68	BETA-GLUCURONIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,1-3-6-TRIHYDROXY:	INACTIVE
69	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,1-3-6-TRIHYDROXY:	INACTIVE
70	SUPEROXIDE PRODUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,1-3-6-TRIHYDROXY:	INACTIVE
71	BETA-GLUCURONIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,1-3-6-TRIHYDROXY:	INACTIVE
72	LYSOZYME RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,1-3-6-TRIHYDROXY:	INACTIVE
73	Not specified	COMPLETE SYNTHESIS REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FOR	GENTISEIN	None
74	BETA-GLUCURONIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GENTISEIN	INACTIVE
75	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GENTISEIN	INACTIVE
76	SUPEROXIDE PRODUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GENTISEIN	WEAK ACTIVITY
77	BETA-GLUCURONIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GENTISEIN	INACTIVE
78	LYSOZYME RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GENTISEIN	WEAK ACTIVITY
79	Not specified	COMPLETE SYNTHESIS REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FOR	XANTHONE,1-3-8-TRIHYDROXY:	None
80	BETA-GLUCURONIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,1-3-8-TRIHYDROXY:	INACTIVE
81	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,1-3-8-TRIHYDROXY:	INACTIVE
82	SUPEROXIDE PRODUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,1-3-8-TRIHYDROXY:	INACTIVE
83	BETA-GLUCURONIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,1-3-8-TRIHYDROXY:	INACTIVE
84	LYSOZYME RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,1-3-8-TRIHYDROXY:	INACTIVE
85	Not specified	COMPLETE SYNTHESIS REPORTED	XANTHONE,1-3-5-6-TETRAHYDROXY:	None
86	BETA-GLUCURONIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,1-3-5-6-TETRAHYDROXY:	INACTIVE
87	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,1-3-5-6-TETRAHYDROXY:	INACTIVE
88	SUPEROXIDE PRODUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,1-3-5-6-TETRAHYDROXY:	WEAK ACTIVITY
89	BETA-GLUCURONIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,1-3-5-6-TETRAHYDROXY:	WEAK ACTIVITY
90	LYSOZYME RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,1-3-5-6-TETRAHYDROXY:	WEAK ACTIVITY
91	Not specified	COMPLETE SYNTHESIS REPORTED	XANTHONE,2-3-6-7-TETRAHYDROXY:	None
92	BETA-GLUCURONIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,2-3-6-7-TETRAHYDROXY:	INACTIVE
93	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,2-3-6-7-TETRAHYDROXY:	INACTIVE
94	SUPEROXIDE PRODUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,2-3-6-7-TETRAHYDROXY:	WEAK ACTIVITY
95	BETA-GLUCURONIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,2-3-6-7-TETRAHYDROXY:	INACTIVE
96	LYSOZYME RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,2-3-6-7-TETRAHYDROXY:	WEAK ACTIVITY
97	Not specified	COMPLETE SYNTHESIS REPORTED	XANTHONE,3-4-5-6-TETRAHYDROXY:	None
98	BETA-GLUCURONIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,3-4-5-6-TETRAHYDROXY:	INACTIVE
99	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,3-4-5-6-TETRAHYDROXY:	INACTIVE
100	SUPEROXIDE PRODUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,3-4-5-6-TETRAHYDROXY:	WEAK ACTIVITY
101	BETA-GLUCURONIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,3-4-5-6-TETRAHYDROXY:	INACTIVE
102	LYSOZYME RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,3-4-5-6-TETRAHYDROXY:	INACTIVE
103	Not specified	COMPLETE SYNTHESIS REPORTED	XANTHONE,3-4-6-7-TETRAHYDROXY:	None
104	BETA-GLUCURONIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,3-4-6-7-TETRAHYDROXY:	INACTIVE
105	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,3-4-6-7-TETRAHYDROXY:	INACTIVE
106	SUPEROXIDE PRODUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,3-4-6-7-TETRAHYDROXY:	WEAK ACTIVITY
107	BETA-GLUCURONIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,3-4-6-7-TETRAHYDROXY:	INACTIVE
108	LYSOZYME RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,3-4-6-7-TETRAHYDROXY:	INACTIVE

Citation 12360

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1